Unlock instant, AI-driven research and patent intelligence for your innovation.

Purification of red blood cells by separation and infiltration

A red blood cell and diafiltration technology, applied in the field of red blood cell purification by separation and diafiltration, can solve the problems of reduced yield, variable processing time, cell lysis, etc., and achieve the effect of increasing yield

Inactive Publication Date: 2007-11-14
HEMOGLOBIN OXYGEN THERAPEUTICS
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Utilization of filtration to wash blood solutions results in very variable processing times which adversely affects product throughput
In addition, the prolongation of the cell washing process can lead to an unacceptable increase in bioburden and to cell lysis, thereby reducing the yield of the process

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Purification of red blood cells by separation and infiltration
  • Purification of red blood cells by separation and infiltration

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0065] Example 1 - Laboratory scale experiments

[0066] Referring to the figure, recover calf whole blood in a container with anticoagulant (EDTA), and at 2,600 rpm (1,200XG), at 4°C, separate the whole blood into the heavy phase (red blood cell component, or cell component ) and the light phase (liquid fraction) in a centrifuge 27 (Beckman J2-21 using a JA-10 centrifuge) for 30 minutes. The starting volume of blood is 200ml. The red blood cell and liquid fractions were separated and the phases were processed in a laboratory-scale cell washing system. Liquid components are processed directly. The red blood cell fraction was directed to the recirculation vessel 28 and diluted to its original volume with isotonic citric acid / salt buffer (sodium citrate hydrate, 6.0 g / L, sodium chloride 8 g / L). The recirculation vessel is maintained at the proper temperature around the recirculation vessel by recirculating the appropriate medium in the recirculation bottle, 30 . Separation ...

Embodiment 2

[0070] Example 2 - Laboratory scale experiment II

[0071] Calf blood was recovered in aseptically processed stainless steel containers containing sodium citrate anticoagulant and batch centrifuged in a second centrifuge type, a CEPA tube-enteric centrifuge (New Brunswick Scientific Corporation, Edison, NJ) Red blood cell component and liquid component. Centrifugation was performed in two feeding configurations. In one configuration, food is pumped in with a peristyle pump, and blood is added in a second configuration using a siphon. The red blood cell fraction obtained from each configuration was then diluted to the original volume of calf blood to produce a blood solution containing isotonic citrate / salt buffer. As a control, citrated whole blood without centrifugation was included as a separate sample. The samples were washed in a bench scale washing apparatus until three retentate volumes of permeate (approximately 600 ml) were obtained. The data are summarized in Ta...

Embodiment 3

[0075] Example 3 - Pilot Scale Experiment

[0076] Blood was pooled from three animals and treated with anticoagulants as described in Example 2. Pooled blood was centrifuged in a Westfalia (Northvale, NJ) SA-1 or SB-7 centrifuge to generate a red blood cell fraction and a liquid fraction, or washed directly as a control. The red blood cell fraction was washed using a pilot-scale washing system.

[0077] Separation of red blood cells was performed through the filter using a pump (Watson-Marlow pump, Wilmington, MA). After passing through the filter, separation of red blood cells was performed by recirculation vessel and diluted with isotonic citrate / salt buffer. The volume of the recirculation vessel is 9.6 liters. The recirculation vessel is maintained at an appropriate temperature by recirculating glycol through recirculation bottles surrounding the recirculation vessel. Separation of the red blood cell fraction / buffer mixture into permeate and retentate was performed ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

Red blood cells are purified by separating whole blood, such as by centrifugation, to form a red blood cell fraction and a liquid fraction. The whole blood can be defibrinated or treated to prevent coagulation prior to separation. Preferably, the whole blood is bovine blood. The red blood cell fraction is then diafiltered to purify the red blood cells. The purified red blood cells can then be lysed to form a lysate of purified red blood cells. The purified red blood cells and the lysate of purified red blood cells are suitable for use in producing hemoglobin blood substitute.

Description

Background of the invention [0001] Emphasis in the development of red blood cell-based oxygen carriers has been focused on oxygen delivery for pharmaceutical therapy, such as blood transfusion and production of blood products. Red blood cell-based oxygen carriers can be used to prevent or treat blood loss (e.g., due to acute bleeding or during surgery), due to anemia (e.g., pernicious anemia or sickle cell anemia), or due to shock (e.g., volume deficient shock , anaphylactic shock, septic shock, or anaphylactic shock) resulting in hypoxia. [0002] Existing red blood cell-based oxygen carriers include hyperfluorinated chemicals, synthetic red blood cell analogs, liposome-encapsulated hemoglobin, chemically modified hemoglobin, and hemoglobin-based oxygen carriers in which red blood cell Molecules are cross-linked. The preparation of red blood cell-based oxygen carriers involves several purification steps. To remove plasma proteins from whole blood, whole blood cells are was...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/42C12N5/06C07K14/805A61P7/08A61K35/16A61M1/36C12N5/078
CPCA61K38/42A61M2202/0429C12N5/0641A61M1/3693A61K35/16A61M1/3692A61M1/3696A61P7/08
Inventor 罗伯特·A·胡特陈斯玛丽亚·S·盖瑞威廉·R·赖特杰夫德·巴卡
Owner HEMOGLOBIN OXYGEN THERAPEUTICS